Spike Glycoprotein (1147-1162) (SARS-CoV-2, SARS-CoV) (trifluoroacetate salt)

Request For Quotation
Spike Glycoprotein (1147-1162) (SARS-CoV-2, SARS-CoV) (trifluoroacetate salt) Suppliers list
Company Name: Cayman Chemical Company  
Tel: 800-364-9897
Email: sales@caymanchem.com
Company Name: Neobioscience Co., Ltd.  
Tel: 4006-800-892
Email: info@neobioscience.com
Spike Glycoprotein (1147-1162) (SARS-CoV-2, SARS-CoV) (trifluoroacetate salt) Basic information
Product Name:Spike Glycoprotein (1147-1162) (SARS-CoV-2, SARS-CoV) (trifluoroacetate salt)
Synonyms:Spike Glycoprotein (1147-1162) (SARS-CoV-2, SARS-CoV) (trifluoroacetate salt)
CAS:
MF:
MW:0
EINECS:
Product Categories:
Mol File:Mol File
Spike Glycoprotein (1147-1162) (SARS-CoV-2, SARS-CoV) (trifluoroacetate salt) Structure
Spike Glycoprotein (1147-1162) (SARS-CoV-2, SARS-CoV) (trifluoroacetate salt) Chemical Properties
solubility Water: Soluble
Safety Information
MSDS Information
Spike Glycoprotein (1147-1162) (SARS-CoV-2, SARS-CoV) (trifluoroacetate salt) Usage And Synthesis
DescriptionSpike glycoprotein (1147-1162) is a peptide corresponding to amino acids 1147-1162 of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike glycoprotein, also known as the surface glycoprotein.1 This peptide is conserved across SARS-CoV, SARS-CoV-2, and various SARS-CoV-2 variants, including B.1.1.7, B.1.1.298, B.1.429, P.2, P.2, B.1.351, and B.1.617.2 and antibodies against this peptide neutralize SARS-CoV-2 and SARS-CoV pseudovirus particles in cellular assays.WARNING This product is not for human or veterinary use.
References[1] TUOFAN LI. A novel linear and broadly neutralizing peptide in the SARS-CoV-2 S2 protein for universal vaccine development[J]. Cellular &Molecular Immunology, 2021, 18 11: 2563-2565. DOI: 10.1038/s41423-021-00778-6
Spike Glycoprotein (1147-1162) (SARS-CoV-2, SARS-CoV) (trifluoroacetate salt) Preparation Products And Raw materials
Tag:Spike Glycoprotein (1147-1162) (SARS-CoV-2, SARS-CoV) (trifluoroacetate salt) Related Product Information
SARS-CoV/SARS-CoV-2 Spike Glycoprotein RBD Chimeric Monoclonal Antibody (Clone D004) SARS-CoV-2 Spike Glycoprotein Receptor Binding Domain Polyclonal Antibody SARS-CoV/SARS-CoV-2 Spike Glycoprotein RBD Chimeric Rabbit-Human Monoclonal Antibody (Clone D006) SARS-CoV-2 Spike Glycoprotein S1 Subunit Rabbit Monoclonal Antibody (Clone 007) SARS-CoV-2 Spike Glycoprotein S1 Subunit Polyclonal Antibody